- Funding will advance development of Rejuvenate’s one-time gene therapy RJB-0402 for the treatment of desmoplakin gene variant arrhythmogenic cardiomyopathy SAN DIEGO--(BUSINESS WIRE)--Rejuvenate Bio ...

Belgian biotech Rejuvenate Biomed has teamed up with data and AI solutions company SAS to create a tool for researchers to repurpose existing drugs to tackle age-related diseases at their core. The ...

They're must-haves for mature skin.

What if we could tackle multiple age-related ailments such as heart failure and kidney failure with a single injection, instead of piling on many different treatments? That’s the goal for Rejuvenate ...

Rejuvenate Bio is a gene therapy startup that seeks to reverse aging. In response to emailed questions, CEO and Co-founder Daniel Oliver talked about how he and his co-founder started the company and ...

SAN DIEGO--(BUSINESS WIRE)--Rejuvenate Bio today announced a partnership with a leading animal health company for the development and commercialization of its novel gene therapy technology for the ...

Drawing from the key conversations at Revitalize 2026, experts confirmed that rejuvenation is a biological reality that can ...

The Wyss Institute for Biologically Inspired Engineering at Harvard University announced today that Rejuvenate Bio has secured an exclusive worldwide license from the Harvard Office of Technology ...